Catalyst Capital Advisors’s Quest Diagnostics DGX Stock Holding History

Catalyst Capital Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.73M	Sell	12,900 -525	-4%	-$103K	0.05%	97
2026 Q1	$2.63M	Sell	13,425 -600	-4%	-$117K	0.05%	95
2025 Q4	$2.43M	Sell	14,025 -550	-4%	-$100K	0.05%	103
2025 Q3	$2.78M	Sell	14,575 -650	-4%	-$115K	0.06%	100
2025 Q2	$2.73M	Sell	15,225 -700	-4%	-$122K	0.06%	97
2025 Q1	$2.69M	Buy	+15,925	New	+$2.62M	0.06%	96
2023 Q2	–	Sell	-1,225	Closed	-$173K	–	346
2023 Q1	$173K	Hold	1,225	–	–	0.01%	196
2022 Q4	$192K	Hold	1,225	–	–	0.01%	194
2022 Q3	$150K	Hold	1,225	–	–	0.01%	209
2022 Q2	$163K	Hold	1,225	–	–	0.01%	226
2022 Q1	$168K	Hold	1,225	–	–	0.01%	248
2021 Q4	$212K	Hold	1,225	–	–	0.01%	222
2021 Q3	$178K	Hold	1,225	–	–	0.01%	239
2021 Q2	$162K	Hold	1,225	–	–	0.01%	253
2021 Q1	$157K	Buy	+1,225	New	+$151K	0.01%	252
2020 Q4	–	Sell	-1,650	Closed	-$189K	–	348
2020 Q3	$189K	Buy	+1,650	New	+$195K	0.01%	239
2016 Q1	–	Sell	-5,650	Closed	-$402K	–	530
2015 Q4	$402K	Buy	+5,650	New	+$380K	0.06%	190
2014 Q3	–	Sell	-106,200	Closed	-$6.23M	–	437
2014 Q2	$6.23M	Buy	106,200 +44,703	+73%	+$2.62M	1.02%	19
2014 Q1	$3.56M	Buy	+61,497	New	+$3.3M	0.81%	29
2013 Q4	–	Sell	-17,783	Closed	-$1.1M	–	266
2013 Q3	$1.1M	Buy	+17,783	New	+$1.06M	0.6%	55

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Catalyst Capital Advisors's DGX Position: Q2 2026 in Review

Catalyst Capital Advisors reduced its Quest Diagnostics (DGX) stake by 3.9% in Q2 2026, selling an estimated $103K and leaving 12,900 shares worth $2.73M. The position accounts for 0.05% of the portfolio, ranked #97.

Catalyst Capital Advisors first reported a position in DGX in Q3 2013 and has held it in 20 quarters since. The position peaked at $6.23M in Q2 2014. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Catalyst Capital Advisors held 12,900 shares of Quest Diagnostics worth $2.73M as of Q2 2026.
Catalyst Capital Advisors sold 525 Quest Diagnostics shares in Q2 2026, an estimated $103K.
Quest Diagnostics made up 0.05% of Catalyst Capital Advisors's portfolio in Q2 2026, its #97 holding.
Catalyst Capital Advisors first reported a position in Quest Diagnostics in Q3 2013 and has held it in 20 quarters since.
Catalyst Capital Advisors's Quest Diagnostics position peaked at $6.23M in Q2 2014.
1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Catalyst Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.